Mylotarg

(gemtuzumab ozogamicin)

gemtuzumab ozogamicin 4.5 MG Injection [Mylotarg]

Dosage & administration

* Newly-diagnosed, de novo AML (combination regimen)
Adults:
* Induction: 3 mg/m2 (up to one 4.5 mg vial) on Days 1, 4, and 7 in combination with daunorubicin and cytarabine .
* Consolidation: 3 mg/m2 on Day 1 (up to one 4.5 mg vial) in combination with daunorubicin and cytarabine .
Pediatric patients 1 month and older:
* 3 mg/m2 for patients with body surface area (BSA) 0.6 m2 or greater .
* 0.1 mg/kg for patients with BSA less than 0.6 m2 .
* See Full Prescribing Information for complete dosing information .

* Newly-diagnosed AML (single-agent regimen):
Adults:
* Induction: 6 mg/m2 (not limited to one 4.5 mg vial) on Day 1 and 3 mg/m2 (not limited to one 4.5 mg vial) on Day 8 .
* Continuation: For patients without evidence of disease progression following induction, up to 8 continuation courses of MYLOTARG 2 mg/m2 (not limited to one 4.5 mg vial) on Day 1 every 4 weeks .

* Relapsed or refractory AML (single-agent regimen):
* Adults and pediatric patients 2 years and older:

* 3 mg/m2 (up to one 4.5 mg vial) on Days 1, 4, and 7 .

* Premedicate with a corticosteroid, antihistamine, and acetaminophen .

Most viewed Mylotarg resources

Enroll in Patient Savings Program

drug label

Mylotarg prescribing information

Contact Medical Science Liaison Report Adverse Event

prior authorization

Mylotarg prior authorization resources

Most recent Mylotarg prior authorization forms

View By Payer

Verified: Apr 07, 2024Kaiser Foundation Health Plan - Chronic High-Dose Opioid Therapy Prior Authorization Form Washington

Verified: Apr 01, 2024Highmark BCBS Northeastern NY - Medicare Prescription Drug Medication Request Form

Verified: Apr 01, 2024Highmark BCBS Northeastern NY - Short Acting Opioid Prior Authorization Form

Verified: Apr 01, 2024Highmark BCBS Western NY - Specialty Drug Prior Authorization Form

Verified: Apr 01, 2024Highmark BCBS Western NY - Non-Formulary Drug Coverage Prior Authorization Form

Most recent state uniform prior authorization forms

Verified: Mar 28, 2024Arizona - Uniform Prior Authorization Form

Verified: Mar 28, 2024Colorado - Uniform Prior Authorization Form

Verified: Mar 28, 2024Hawaii - Uniform Prior Authorization Form

Verified: Mar 28, 2024Illinois - Uniform Prior Authorization Form

Verified: Mar 28, 2024Indiana - Uniform Prior Authorization Form

Verified: Mar 28, 2024Louisiana - Uniform Prior Authorization Form

Verified: Mar 28, 2024Minnesota - Uniform Prior Authorization Form

Verified: Mar 28, 2024New Hampshire - Uniform Prior Authorization Form

Verified: Mar 28, 2024New Mexico - Uniform Prior Authorization Form

Verified: Mar 28, 2024Oregon - Uniform Prior Authorization Form

Verified: Mar 28, 2024Texas - Uniform Prior Authorization Form

Complete Letter of Medical Necessity

Coverage Authorization Appeal

Formulary Exception Letter

Learn More

Benefits investigation

Pfizer Oncology Together Form

Pfizer Oncology Together Form - Spanish

Learn More

Reimbursement help (FRM)

Receive Assistance from an FRM Regarding Reimbursement Information

Learn More

pharmacy

Mylotarg preferred pharmacy

Pharmacy List

financial assistance

Mylotarg financial assistance options

Co-pay savings program

commercial only

Pfizer Oncology Together Form

Pfizer Oncology Together Form - Spanish

Enroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Foundation programs

under insured

no insurance

goverment insurance

65+

Pfizer Oncology Together Form

Pfizer Oncology Together Form - Spanish

Pfizer Patient Assistance Program

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

PubMed™ | Mylotarg

Mylotarg PubMed™ News

patient education

Mylotarg patient education

To share resource; ask patient to:

1.Pull out phone

2.Open camera

3.Scan QR code with camera

4.Tap link

Patient toolkit

Pfizer Oncology Patient Access Guide

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Pfizer Oncology Patient Access Guide - Spanish

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Learn More

Mylotarg FAQs

How is the dosage of Mylotarg?Mylotarg is available in 1 dosages, including 4.5 mg Injection

What does Mylotarg treat?Mylotarg treats Acute Myeloid Leukemia and Acute Myelomonocytic Leukemia

What is Mylotarg made of?Mylotarg contains gemtuzumab ozogamicin which is a CD33-directed Immunoconjugate

How Is Mylotarg Administered?Mylotarg is administered as a Injectable

What Are The Mylotarg Mechanism Of Action?Mylotarg mechanism of action is CD33-directed Antibody Interactions

FAQ Data Source

Mylotarg

Dosage & administration

Most viewed Mylotarg resources

drug label

Mylotarg prescribing information

prior authorization

Mylotarg prior authorization resources

Most recent Mylotarg prior authorization forms

Most recent state uniform prior authorization forms

Benefits investigation

Reimbursement help (FRM)

pharmacy

Mylotarg preferred pharmacy

financial assistance

Mylotarg financial assistance options

Co-pay savings program

Foundation programs

PubMed™ | Mylotarg

Mylotarg PubMed™ News

patient education

Mylotarg patient education

Patient toolkit

people also ask

Mylotarg FAQs